Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Short course intermittent chemotherapy in childhood tuberculosis

Intermittierende Kurzzeit-Chemotherapie bei Tuberkulose im Kindesalter

  • 38 Accesses

  • 12 Citations


A total of 130 children diagnosed as having pulmonary and extrapulmonary tuberculosis who received short course intermittent chemotherapy between 1978–1992 were evaluated retrospectively. One hundred and ten children with tuberculosis were treated with isoniazid (10–15 mg/kg, maximum 400 mg), rifampin (10–15 mg/kg, maximum 600 mg), and streptomycin (30 mg/kg, maximum 1 g) daily, for 15 days. Treatment was completed with similar doses of isoniazid and rifampin twice a week for a period of 9 months. Since 1986, 20 children with tuberculosis were being treated with the same regimen but without streptomycin. The majority of patients in these cases had pulmonary tuberculosis (75%), followed by lymph nodes (9%), pleural (7%), bone and joint (5%), miliary (3%), and abdominal tuberculosis (1%). The clinicoradiologic response to treatment was observed to be excellent. Only one case of relapse was detected, which was the case of a patient with lymph node tuberculosis that occurred 18 months after the completion of treatment. No serious adverse drug reaction was observed in any of the cases mentioned. In conclusion, short-course low-dose intermittent chemotherapy is an effective and economical treatment with minimal side effects for pulmonary and extrapulmonary tuberculosis in childhood.


Zwischen 1978 und 1986 wurden in der Abteilung für Pneumologie im Kinderkrankenhaus Hacettepe 110 Patienten mit Tuberkulose 2 Wochen lang täglich mit Isoniazid (10–15 mg/kg, Maximum 400 mg/d), Rifampicin (10–15 mg/kg, Maximum 600 mg/d) und Streptomycin (30 mg/kg, Maximum 1 g/d) behandelt. Danach wurde die Therapie mit Isoniazid und Rifampicin zweimal wöchentlich in der gleichen Dosierung für insgesamt 9 Monate weitergeführt. Ab 1986 wurden 20 Patienten diesmal ohne Streptomycin also nur mit Isoniazid und Rifampicin in der gleichen Weise behandelt. Die Mehrzahl der Patienten hatte Lungentuberkulose (75%), außerdem lagen in 9% der Fälle Lymphknoten-, 7% Pleura-, 5% Gelenk- und Knochentuberkulosen, 3% miliäre und 1% abdominale Tuberkulosen vor. Bei allen Patienten war die Behandlung erfolgreich. Bei der Langzeit-Beobachtung wurde bei einem Patienten mit Lymphknotentuberkulose ein Rückfall festgestellt. Außer einem vorübergehenden Transaminasenanstieg bei einem Patienten wurden keine Nebenwirkungen beobachtet. Die kurzfristige, niedrig dosierte Intermittierende Therapie wird als eine ökonomische Therapie, mit geringen Nebenwirkungen für verschiedene Formen pulmonaler und extrapulmonaler Tuberkulose im Kindesalter vorgeschlagen.

This is a preview of subscription content, log in to check access.


  1. 1.

    World Health Organization: Tuberculosis Control Program. Geneva, 2–3 May 1991.

  2. 2.

    Dickinson, J. M., Mitchison, D. A. Short-term intermittent chemotherapy of experimental tuberculosis in the guinea pig. Tubercle 47 (1966) 381–393.

  3. 3.

    Grumbach, F., Canetti, G., Grosset, J., Lirzin, M. L. Late results of long-term intermittent chemotherapy of advanced, murine tuberculosis: limits of the murine model. Tubercle 48 (1967) 11–26.

  4. 4.

    Tuberculosis Chemotherapy Centre, Madras A concurrent comparison of intermittent (twice weekly) isoniazid plus streptomycin and daily isoniazid plus PAS in the domiciliary treatment of pulmonary tuberculosis. Bull. WHO 31 (1964) 247–271.

  5. 5.

    Hudson, L. D., Sbarbaro, J. A. Twice weekly tuberculosis chemotherapy. JAMA 223 (1973) 139–143.

  6. 6.

    British Thoracic and Tuberculosis Association Short-course chemotherapy in pulmonary tuberculosis. Lancet ii (1976) 1102–1104.

  7. 7.

    Algerian Working Group / British Medical Research Council Controlled clinical trial comparing a 6 month and a 12 month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Am. Rev. Respir. Dis. 129 (1984) 921–928.

  8. 8.

    East and Central African / British Medical Research Council Fifth Collaborative Study Controlled clinical trial of 4 short course regimens of chemotherapy (three 6 month and one 8 month) for pulmonary tuberculosis: final report. Tubercle 67 (1986) 5–15.

  9. 9.

    Fox, W., Mitchison, D. A. Short course chemotherapy for pulmonary tuberculosis. Am. Rev. Respir. Dis. 111 (1975) 325–353.

  10. 10.

    Fox, W. The modern management and therapy of pulmonary tuberculosis. Proc. Roy. Soc. Med. 70 (1977) 4–15.

  11. 11.

    Fox, W. Whither short-course chemotherapy? Br. J. Dis. Chest. 75 (1981) 331–357.

  12. 12.

    Pai, C. H., Gillis, F., Marks, M. I. Present chemotherapy for tuberculosis. J. Infect. Dis. 146 (1982) 698–705.

  13. 13.

    Mitchison, D. A. The action of antituberculosis drugs in short course chemotherapy. Tubercle 66 (1985) 219–225.

  14. 14.

    American Thoracic Society Treatment of tuberculosis and tuberculosis infection in adults and children. Am. Rev. Respir. Dis. 134 (1986) 355–363.

  15. 15.

    Dutt, A. K., Jones, L., Stead, W. W. Short-course chemotherapy for tuberculosis with largely twice weekly isoniazid-rifampin. Chest 75 (1979) 441–447.

  16. 16.

    Dutt, A. K., Stead, W. W. Short-course chemotherapy. The Arkansas experience. Chest 80 (1981) 724–727.

  17. 17.

    Abernathy, R. S., Dutt, A. K., Stead, W. W., Moers, D. J. Short-course chemotherapy for tuberculosis in children. Pediatrics 72 (1983) 801–806.

  18. 18.

    Biddulph, J., Kokoha, V., Sharma, S. Short-course chemotherapy in childhood tuberculosis. J. Trop. Ped. 34 (1988) 20–23.

  19. 19.

    Reis, F. J., Bedran, M. B. M., Maura, J. A. R., Assis, I., Rodrigues, M. E. S. M. Six month isoniazid-rifampin treatment for pulmonary tuberculosis in children. Am. Rev. Respir. Dis. 142 (1990) 996–999.

  20. 20.

    Biddulph, J. Short-course chemotherapy for childhood tuberculosis. Ped. Infect. Dis. J. 9 (1990) 794–801.

  21. 21.

    Kumar, L., Dhand, R., Singhi, P. D., Rao, K. L. N., Katariya, S. A randomized trial of fully intermittent vs. daily followed by intermittent short course chemotherapy for childhood tuberculosis. Ped. Infect. Dis. J. 9 (1990) 802–806.

  22. 22.

    Committee on Infectious Diseases. American Academy of Pediatrics Chemotherapy for tuberculosis in infants and children. Pediatrics 89 (1992) 161–165.

Download references

Author information

Correspondence to Prof. A. Göçmen M. D..

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Göçmen, A., Özçelic, U., Kiper, N. et al. Short course intermittent chemotherapy in childhood tuberculosis. Infection 21, 324–327 (1993). https://doi.org/10.1007/BF01712456

Download citation


  • Tuberculosis
  • Rifampicin
  • Adverse Drug Reaction
  • Isoniazid
  • Rifampin